STERIS plc (STE) Stock Price

STERIS plc Price

Frankfurt·CLOSED
237.47USD+5.69 (+2.43 %)
Market closed

Revenue has compounded at 8.8% per year over the past 19 years to 5.94 B USD. Earnings per share have grown at 10.1% per year over the last 19 years. STERIS plc's net margin stands at 13.2%, up from 5.8% several years earlier. STERIS plc currently offers a dividend yield of about 1.04%. The payout ratio is around 93% of earnings. The dividend has grown at 13.5% per year over the past 19 years. Analysts set a median price target of 296.82 USD, implying 25.0% above the current price. Of 14 analysts, 9 rate the stock a buy — an overall Buy consensus. The stock trades about 19% above its 52-week low.

STERIS plc stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of STERIS plc over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how STERIS plc stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing STERIS plc's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

STERIS plc Stock Price History
DateSTERIS plc Price
8/7/2026237.47 USD
8/6/2026231.78 USD
8/5/2026229.51 USD
8/4/2026233.04 USD
8/3/2026232.64 USD
7/31/2026228.40 USD
7/30/2026231.21 USD
7/29/2026233.04 USD
7/27/2026219.66 USD
7/23/2026210.64 USD
7/22/2026210.57 USD
7/21/2026211.75 USD
7/20/2026214.47 USD
7/17/2026217.84 USD
7/16/2026221.13 USD
7/15/2026211.46 USD
7/14/2026208.73 USD
7/13/2026215.26 USD
7/10/2026216.00 USD
7/9/2026216.00 USD
7/8/2026213.12 USD
7/7/2026215.39 USD
7/6/2026213.23 USD
7/2/2026218.20 USD
7/1/2026212.30 USD
6/30/2026210.57 USD
6/29/2026214.93 USD
6/26/2026215.67 USD
6/25/2026210.60 USD
6/24/2026207.17 USD
6/23/2026203.21 USD
6/22/2026200.26 USD
6/18/2026202.61 USD
6/17/2026199.40 USD
6/16/2026206.51 USD
6/15/2026205.93 USD
6/12/2026207.56 USD
6/11/2026207.22 USD
6/10/2026208.10 USD
6/5/2026212.35 USD
6/4/2026212.24 USD
6/3/2026210.19 USD
6/2/2026209.76 USD
6/1/2026211.07 USD
5/29/2026212.73 USD
5/28/2026215.40 USD
5/27/2026212.87 USD
5/26/2026216.27 USD
5/22/2026216.57 USD
5/21/2026219.67 USD
5/20/2026215.97 USD
5/19/2026214.42 USD
5/14/2026215.98 USD
5/13/2026211.10 USD
5/4/2026212.25 USD
5/1/2026214.40 USD
4/30/2026216.88 USD
4/29/2026212.65 USD
4/28/2026219.75 USD
4/27/2026222.19 USD
4/24/2026221.80 USD
4/23/2026223.52 USD
4/22/2026223.55 USD
4/21/2026219.45 USD
4/20/2026226.41 USD
4/17/2026225.79 USD
4/16/2026219.97 USD
4/15/2026221.50 USD
4/14/2026224.83 USD
4/13/2026224.85 USD
4/10/2026222.58 USD
4/9/2026223.75 USD
4/8/2026225.03 USD
4/7/2026219.22 USD
4/6/2026219.97 USD
4/2/2026218.71 USD
4/1/2026219.94 USD
3/31/2026221.13 USD
3/30/2026219.38 USD
3/27/2026219.40 USD
3/26/2026223.43 USD
3/25/2026223.38 USD
3/24/2026221.73 USD
3/23/2026221.00 USD
3/20/2026220.03 USD
3/19/2026217.92 USD
3/18/2026217.92 USD
3/17/2026220.13 USD
3/16/2026219.05 USD
3/13/2026214.57 USD
3/12/2026212.35 USD
3/11/2026221.55 USD
3/10/2026222.08 USD
3/9/2026227.72 USD
3/6/2026230.51 USD
3/5/2026238.51 USD
3/4/2026243.07 USD
3/3/2026243.35 USD
3/2/2026247.77 USD
2/27/2026252.35 USD
2/26/2026257.64 USD
2/25/2026251.62 USD
2/24/2026246.74 USD
2/23/2026247.11 USD
2/20/2026250.65 USD
2/19/2026251.18 USD
2/18/2026249.35 USD
2/17/2026245.41 USD
2/13/2026248.35 USD
2/12/2026244.22 USD
2/11/2026243.47 USD
2/10/2026244.67 USD
2/9/2026245.40 USD
2/6/2026252.16 USD
2/5/2026243.81 USD
2/4/2026264.27 USD
2/3/2026261.67 USD
2/2/2026264.24 USD
1/30/2026262.60 USD
1/29/2026261.64 USD
1/28/2026260.86 USD
1/27/2026263.07 USD
1/26/2026263.13 USD
1/23/2026259.52 USD
1/22/2026260.90 USD
1/21/2026261.18 USD
1/20/2026258.00 USD
1/16/2026268.65 USD
1/15/2026268.26 USD
1/14/2026264.25 USD
1/13/2026259.87 USD
1/12/2026260.77 USD
1/9/2026256.83 USD
1/8/2026260.68 USD
1/7/2026259.20 USD
1/6/2026260.03 USD
1/5/2026256.75 USD
1/2/2026250.04 USD
12/31/2025253.52 USD
12/30/2025255.47 USD
12/29/2025256.22 USD
12/26/2025255.42 USD
12/24/2025255.68 USD
12/23/2025255.39 USD
12/22/2025255.13 USD
12/19/2025254.34 USD
12/18/2025251.55 USD
12/17/2025251.67 USD
12/16/2025253.03 USD
12/15/2025254.07 USD
12/12/2025251.79 USD
12/11/2025252.49 USD
12/10/2025258.84 USD
12/9/2025257.27 USD
12/8/2025261.41 USD
12/5/2025263.28 USD
12/4/2025261.02 USD
12/3/2025259.40 USD
12/2/2025259.30 USD
12/1/2025262.89 USD
11/28/2025266.28 USD
11/26/2025266.85 USD
11/25/2025267.79 USD
11/24/2025263.08 USD
11/21/2025263.29 USD
11/20/2025256.98 USD
11/19/2025254.71 USD
11/18/2025257.00 USD
11/17/2025257.01 USD
11/14/2025258.41 USD
11/13/2025260.44 USD
11/12/2025267.99 USD
11/11/2025266.70 USD
11/10/2025264.01 USD
11/7/2025263.77 USD
11/6/2025260.06 USD
11/5/2025243.18 USD
11/4/2025241.85 USD
11/3/2025237.32 USD
10/31/2025235.70 USD
10/30/2025236.19 USD
10/29/2025236.79 USD
10/28/2025241.20 USD
10/27/2025240.91 USD
10/24/2025240.77 USD
10/23/2025241.85 USD
10/22/2025242.37 USD
10/21/2025242.03 USD
10/20/2025242.22 USD
10/17/2025240.21 USD
10/16/2025240.30 USD
10/15/2025236.76 USD
10/14/2025237.81 USD
10/13/2025235.48 USD
10/10/2025235.83 USD
10/9/2025239.42 USD
10/8/2025242.33 USD
10/7/2025241.56 USD
10/6/2025240.64 USD
10/3/2025242.31 USD
10/2/2025242.40 USD
10/1/2025241.30 USD
9/30/2025247.44 USD
9/29/2025245.37 USD
9/28/2025245.37 USD
9/25/2025249.08 USD
9/24/2025244.19 USD
9/23/2025249.23 USD
9/22/2025249.71 USD
9/19/2025248.79 USD
9/18/2025250.50 USD
9/17/2025248.79 USD
9/16/2025247.99 USD
9/15/2025247.81 USD
9/12/2025250.56 USD
9/11/2025252.43 USD
9/10/2025243.83 USD
9/9/2025248.39 USD
9/8/2025248.32 USD
9/5/2025245.31 USD
9/4/2025243.39 USD
9/3/2025242.46 USD
9/2/2025242.02 USD
8/29/2025245.07 USD
8/28/2025244.77 USD
8/27/2025248.98 USD
8/26/2025248.58 USD
8/25/2025248.48 USD
8/22/2025251.87 USD
8/21/2025247.50 USD
8/20/2025249.55 USD
8/19/2025247.62 USD
8/18/2025244.56 USD
8/15/2025245.86 USD
8/14/2025246.14 USD
8/13/2025247.07 USD
8/12/2025243.76 USD
8/11/2025241.62 USD
Access this data via the Eulerpool API
Get Free API Key

STERIS plc Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
4.22 B USD
477.82 M USD
243.89 M USD
Jan 1, 2023
4.54 B USD
791.10 M USD
107.03 M USD
Jan 1, 2024
5.14 B USD
836.12 M USD
378.24 M USD
Jan 1, 2025
5.46 B USD
866.64 M USD
614.64 M USD
Jan 1, 2026
5.94 B USD
1.10 B USD
785.10 M USD
Jan 1, 2027 (e)
6.36 B USD
1.59 B USD
1.11 B USD
Jan 1, 2028 (e)
6.77 B USD
1.70 B USD
1.21 B USD
Jan 1, 2029 (e)
7.18 B USD
1.80 B USD
1.31 B USD

STERIS plc Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 10, 2026, 8:04 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITB USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
20142015201620172018201920202021202220232024202520262027e2028e2029e
1.621.852.242.612.622.783.033.114.224.545.145.465.946.366.777.18
8.0614.0620.9716.710.316.188.912.5435.927.4113.276.258.727.186.356.19
40.0141.8439.9939.2841.6842.2043.5643.2244.5943.6543.1744.0044.2544.2544.2544.25
0.650.770.901.031.091.171.321.341.881.982.222.402.632.812.993.18
0.210.230.210.230.400.410.540.550.480.790.840.871.101.591.701.80
12.7012.279.478.6515.2314.7717.7217.6411.3017.4416.2715.8618.5525.0425.0625.06
0.130.140.110.110.290.300.410.400.240.110.380.610.791.111.211.31
-18.874.65-18.52-0.91166.064.8333.88-2.46-38.79-55.97253.2762.4327.8540.769.148.37
0.880.961.061.181.301.421.541.661.801.982.182.402.462.522.763.02
10.009.0910.4211.3210.179.238.457.798.4310.0010.1010.092.502.449.529.42
60.1577.7185.0785.7285.4485.6386.03100.83100.1799.3598.9498.8098.4098.4098.4098.40
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales STERIS plc generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue STERIS plc retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare STERIS plc's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares STERIS plc has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against STERIS plc's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

STERIS plc stock margins

The STERIS plc margin analysis displays the gross margin, EBIT margin, as well as the profit margin of STERIS plc. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for STERIS plc.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
44.59 %
11.31 %
5.77 %
Jan 1, 2023
43.66 %
17.44 %
2.36 %
Jan 1, 2024
43.17 %
16.27 %
7.36 %
Jan 1, 2025
44.01 %
15.87 %
11.26 %
Jan 1, 2026
44.25 %
18.56 %
13.23 %
Jan 1, 2027 (e)
44.25 %
25.06 %
17.37 %
Jan 1, 2028 (e)
44.25 %
25.06 %
17.84 %
Jan 1, 2029 (e)
44.25 %
25.06 %
18.20 %

STERIS plc Stock Revenue, EBIT, Earnings per Share

The STERIS plc earnings per share therefore indicates how much revenue STERIS plc has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2022
42.16 USD
4.77 USD
2.43 USD
Jan 1, 2023
45.66 USD
7.96 USD
1.08 USD
Jan 1, 2024
51.94 USD
8.45 USD
3.82 USD
Jan 1, 2025
55.26 USD
8.77 USD
6.22 USD
Jan 1, 2026
60.32 USD
11.20 USD
7.98 USD
Jan 1, 2027 (e)
64.21 USD
16.20 USD
11.16 USD
Jan 1, 2028 (e)
68.29 USD
17.23 USD
12.18 USD
Jan 1, 2029 (e)
72.52 USD
18.29 USD
13.20 USD

STERIS plc business model & stock analysis

Steris plc is a global provider of products and services in the field of sterilization and disinfection. The company was founded in the United States in 1985 and became an Irish company with headquarters in Dublin in 2015. Steris plc's business model is based on offering solutions for the sterilization and disinfection of medical devices, rooms, and instruments. The company offers a wide range of products and services, including machines and equipment, chemicals and consumables, as well as consulting and training services. Steris plc is divided into several business segments, each focused on specific customer needs. The Healthcare Products division provides solutions for hospitals and medical facilities, including cleaning and disinfecting agents, surgical instruments, and sterilization equipment. The Life Sciences division offers products and services for biotechnology, pharmaceutical, and medical device companies, such as cleaning and sterilization services that comply with FDA regulations. Another important area of Steris plc is Applied Sterilization Technologies, which offers customized solutions for customers in various industries. These range from sterilizing food and beverages to industrial applications such as sterilizing materials in the automotive industry. In addition to offering products and services, Steris plc also specializes in consulting and training for customers. The company provides a wide range of training and seminars to ensure optimal use of sterilization and disinfection products and maximize safety and efficiency. One of Steris plc's most well-known products is the "STERIS V-PRO" system. This system is an automated sterilizer that allows for rapid sterilization of medical instruments and devices. Unlike traditional sterilization methods, this system uses high-energy waves for sterilization, making it possible to sterilize sensitive instruments and materials that may not be possible with conventional methods. Another product of Steris plc is the "SYSTEM 1" sterilization process, used for the sterilization of flexible endoscopes. This process is particularly efficient and effective, sterilizing the endoscopes quickly and thoroughly without causing damage during the process. Steris plc is a pioneer in the field of sterilization and disinfection and has established itself as a leading provider in this field. The company aims to develop innovative solutions to help customers worldwide meet their sterilization and disinfection requirements optimally.

STERIS plc SWOT Analysis

Strengths

  • Strong market presence and leading position in the healthcare industry.
  • Diversified product portfolio offering a wide range of solutions for infection prevention, surgical equipment, and sterilization services.
  • Robust research and development capabilities enabling innovation and technological advancements.
  • Strong distribution network and global reach, allowing access to a large customer base.
  • Established brand reputation for quality and reliability.
  • Strong financial performance and stability, with consistent revenue growth and profitability.
  • Well-established partnerships and collaborations with healthcare providers and institutions.

Weaknesses

  • Reliance on a single industry, healthcare, making the company vulnerable to fluctuations in the sector.
  • Limited geographical diversification, with a significant portion of revenue generated from North America.
  • Limited presence in emerging markets, potentially missing out on growth opportunities.
  • Lack of pricing power due to intense competition in the market.
  • Challenges in integrating acquired businesses and managing potential cultural differences.

Opportunities

  • Growing global healthcare expenditure, providing opportunities for increased demand for Steris' products and services.
  • Expansion into emerging markets with a rising need for infection prevention and sterilization solutions.
  • Technological advancements and increased adoption of minimally invasive surgeries, creating demand for innovative surgical equipment.
  • Strategic acquisitions and partnerships to enhance product offerings and enter new market segments.
  • Increasing focus on patient safety and infection control, driving demand for Steris' products and services.
  • Potential growth in telemedicine and home healthcare, requiring specialized equipment and services.

Threats

  • Intense competition from both established players and new entrants in the healthcare industry.
  • Regulatory challenges and compliance requirements impacting product development and market access.
  • Economic downturns and budget constraints in the healthcare sector, leading to reduced spending on equipment and services.
  • Potential disruptions in the supply chain, affecting the availability of raw materials and components.
  • Shifts in customer preferences or negative perception regarding Steris' products or services.
  • Technological advancements or disruptive innovations that could render current solutions obsolete.

STERIS plc Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

STERIS plc Employees
Details
Date
STERIS plc Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees
Jan 1, 2026
- Employees

STERIS plc Segments

STERIS plc Revenue by Segment (1/7)

  • 3 Years

  • 5 Years

  • Max

Product
Service
Capital equipment revenues
Consumable revenues
Service revenues
Details
Date
Product
Service
Capital equipment revenues
Consumable revenues
Service revenues
Jan 1, 2019
1.30 B USD
1.49 B USD
568.81 M USD
161.78 M USD
114.06 M USD
Jan 1, 2020
1.40 B USD
1.63 B USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

STERIS plc Revenue by Segment (2/7)

  • 3 Years

  • 5 Years

  • Max

Product
Service
Capital equipment revenues
Consumable revenues
Service revenues
Details
Date
Product
Service
Capital equipment revenues
Consumable revenues
Service revenues
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
112.75 M USD
185.90 M USD
118.29 M USD
Jan 1, 2021
1.44 B USD
1.66 B USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
2.87 B USD
2.59 B USD
0.00 USD
0.00 USD
0.00 USD

STERIS plc Revenue by Segment (3/7)

  • 3 Years

  • 5 Years

  • Max

Service
Capital equipment revenues
Consumables
Consumable revenues
Service revenues
Capital equipment
Details
Date
Service
Capital equipment revenues
Consumables
Consumable revenues
Service revenues
Capital equipment
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
128.36 M USD
0.00 USD
215.01 M USD
124.19 M USD
0.00 USD
Jan 1, 2025
138.08 M USD
0.00 USD
286.66 M USD
0.00 USD
0.00 USD
117.53 M USD

STERIS plc Revenue by Segment (4/7)

  • 3 Years

  • 5 Years

  • Max

OperatingSegmentAll
OperatingSegmentAllExceptCorpandOther
Healthcare Products
Applied Sterilization Technologies
Healthcare member
Life Science Member
Healthcare Specialty Services
Details
Date
OperatingSegmentAll
OperatingSegmentAllExceptCorpandOther
Healthcare Products
Applied Sterilization Technologies
Healthcare member
Life Science Member
Healthcare Specialty Services
Jan 1, 2019
2.78 B USD
2.78 B USD
1.34 B USD
555.13 M USD
0.00 USD
378.56 M USD
510.06 M USD
Jan 1, 2020
3.03 B USD
3.03 B USD
1.42 B USD
627.15 M USD
563.61 M USD
416.94 M USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

STERIS plc Revenue by Segment (5/7)

  • 3 Years

  • 5 Years

  • Max

Healthcare
AST
Applied Sterilization Technologies
Life Science Member
Details
Date
Healthcare
AST
Applied Sterilization Technologies
Life Science Member
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
1.95 B USD
0.00 USD
685.91 M USD
467.55 M USD
Jan 1, 2025
0.00 USD
1.04 B USD
0.00 USD
542.27 M USD

STERIS plc Revenue by Segment (6/7)

  • 3 Years

  • 5 Years

  • Max

OperatingSegmentAll
OperatingSegmentAllExceptCorpandOther
Details
Date
OperatingSegmentAll
OperatingSegmentAllExceptCorpandOther
Jan 1, 2019
0.00 USD
0.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
Jan 1, 2021
3.11 B USD
3.11 B USD
Jan 1, 2025
0.00 USD
0.00 USD

STERIS plc Revenue by Segment (7/7)

  • Max

Healthcare Segment
Details
Date
Healthcare Segment
Jan 1, 2019
0.00 USD
Jan 1, 2020
0.00 USD
Jan 1, 2021
0.00 USD
Jan 1, 2025
3.88 B USD

STERIS plc Revenue by Region

  • 3 Years

  • 5 Years

  • Max

United States
Other foreign locations
IRELAND
UNITED KINGDOM
Details
Date
United States
Other foreign locations
IRELAND
UNITED KINGDOM
Jan 1, 2019
1.98 B USD
748.57 M USD
0.00 USD
56.78 M USD
Jan 1, 2020
2.21 B USD
755.35 M USD
63.82 M USD
0.00 USD
Jan 1, 2021
2.23 B USD
808.58 M USD
71.91 M USD
0.00 USD
Jan 1, 2022
3.23 B USD
1.27 B USD
82.01 M USD
0.00 USD
Jan 1, 2024
3.75 B USD
1.30 B USD
82.70 M USD
0.00 USD
Jan 1, 2025
4.01 B USD
1.34 B USD
107.32 M USD
0.00 USD

STERIS plc Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

STERIS plc historical P/E ratio, EBIT multiple, and P/S ratio

STERIS plc annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

STERIS plc shares outstanding

The number of shares of STERIS plc was 98.8 M in 2025. This indicates how many shares STERIS plc is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2022
100.17 M Stocks
Jan 1, 2023
99.35 M Stocks
Jan 1, 2024
98.94 M Stocks
Jan 1, 2025
98.80 M Stocks
Jan 1, 2026
98.40 M Stocks
Jan 1, 2027 (e)
98.40 M Stocks
Jan 1, 2028 (e)
98.40 M Stocks
Jan 1, 2029 (e)
98.40 M Stocks

STERIS plc stock splits

In STERIS plc's history, there have been no stock splits.

STERIS plc Dividend History

22 years of dividend payments · 20 consecutive increases

YearAnnual DividendYoY ChangePayments
20261.26USDYTD—2×
Feb 17, 20260.63USD 0.0%1/2
Jun 8, 20260.63USD 0.0%2/2
20252.40USD↑ 10.1%4×
Feb 20, 20250.57USD 0.0%1/4
Jun 10, 20250.57USD 0.0%2/4
Sep 4, 20250.63USD↑ 10.5%3/4
Nov 18, 20250.63USD 0.0%4/4
20242.18USD↑ 10.1%4×
20231.98USD↑ 10.0%4×
20221.80USD↑ 8.4%4×
20211.66USD↑ 7.8%4×
20201.54USD↑ 8.5%4×
20191.42USD↑ 9.2%4×
20181.30USD↑ 10.2%4×
20171.18USD↑ 11.3%4×

STERIS plc dividend history and estimates

In 2025, STERIS plc paid a dividend amounting to 2.40 USD. Dividend means that STERIS plc distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2022
1.80 USD
0.00 USD
Jan 1, 2023
1.98 USD
0.00 USD
Jan 1, 2024
2.18 USD
0.00 USD
Jan 1, 2025
2.40 USD
0.00 USD
Jan 1, 2026
2.46 USD
0.00 USD
Jan 1, 2027 (e)
0.63 USD
1.89 USD
Jan 1, 2028 (e)
0.00 USD
2.76 USD
Jan 1, 2029 (e)
0.00 USD
3.02 USD

STERIS plc dividend payout ratio

In 2025, STERIS plc had a payout ratio of 38.58%. The payout ratio indicates the percentage of the company's profits that STERIS plc distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2022
73.93 %
Jan 1, 2023
183.80 %
Jan 1, 2024
57.03 %
Jan 1, 2025
38.58 %
Jan 1, 2026
93.13 %
Jan 1, 2027 (e)
22.59 %
Jan 1, 2028 (e)
22.63 %
Jan 1, 2029 (e)
22.85 %

Current STERIS plc forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.68 %
Buy
64.29 % (9)
Hold
35.71 % (5)
Sell
0.00 % (0)
12M Price Target
296.82
Last Price
237.47
Currency
USD
12M Return Potential
24.99 %
LTM Return
0 %

STERIS plc Analyst Rating Actions

DateFirmActionRatingReliability
5/13/2026
Keybanc
Keybanc
MaintainedOverweight49
8/8/2025
Morgan Stanley
Morgan Stanley
MaintainedOverweight60
7/22/2025
Keybanc
Keybanc
MaintainedOverweight49
7/15/2025
Morgan Stanley
Morgan Stanley
UpgradeEqual WeightOverweight60
5/19/2025
Morgan Stanley
Morgan Stanley
MaintainedEqual Weight60
5/16/2025
JMP Securities
JMP Securities
MaintainedMarket Outperform–
5/15/2025
Stephens & Co.
Stephens & Co.
MaintainedOverweight–
5/12/2025
Morgan Stanley
Morgan Stanley
MaintainedEqual Weight60
4/10/2025
JMP Securities
JMP Securities
MaintainedMarket Outperform–
4/7/2025
Needham
Needham
MaintainedHold70

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

STERIS plc Earnings Calls

2025

STERIS plc Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/10/20262.53USD-1.51 BUSD-2027 Q1
5/11/20262.88USD-1.61 BUSD-2026 Q4
2/11/20262.56USD-1.50 BUSD-2026 Q3
5/8/20242.49USD-1.47 BUSD-2024 Q4
2/6/20242.20USD-1.37 BUSD-2024 Q3
11/7/20232.24USD-1.29 BUSD-2024 Q2
7/31/20232.10USD-1.25 BUSD-2024 Q1
5/9/20232.37USD-1.33 BUSD-2023 Q4
2/6/20232.23USD-1.29 BUSD-2023 Q3
11/9/20222.00USD-1.24 BUSD-2023 Q2
...

EESG©

Eulerpool ESG Scorecard© for the STERIS plc stock

67/100
73
Environment
99
Social
29
Governance
E

Environment

20
Scope 1 - Direct Emissions57,543
Scope 2 - Indirect emissions from purchased energy96,291
Scope 3 - Indirect emissions within the value chain321,013
Total CO₂ emissions153,834
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees34.91
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

STERIS plc shareholder structure

% Name
9.11145%
BLACKROCK, INC.
BLACKROCK, INC.
6.42621%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
5.03878%
STATE STREET CORP
STATE STREET CORP
4.99656%
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC
4.43556%
MORGAN STANLEY
MORGAN STANLEY
4.04804%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
...

STERIS plc Beneficial Ownership Filings (SEC 13D/G)

Free Float
99.7%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
11.38%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
10.40%
STERIS plc
STERIS plc
SEC ↗
10.40%
Solar New US Holding Co, LLC
Solar New US Holding Co, LLC
SEC ↗
10.40%
Crystal Merger Sub 1, LLC
Crystal Merger Sub 1, LLC
SEC ↗
7.48%
Vanguard Capital Management
Vanguard Capital Management
SEC ↗
5.10%
STATE STREET CORPORATION
STATE STREET CORPORATION
SEC ↗
5.05%
Vanguard Portfolio Management
Vanguard Portfolio Management
SEC ↗
5.00%
04-2747644
04-2747644
SEC ↗
4.90%
Massachusetts Financial Services Company
Massachusetts Financial Services Company
SEC ↗
3.80%
EIN #00-0000000
EIN #00-0000000
SEC ↗

STERIS plc Executives and Management Board

17 members · avg. age 60 · 35 % women

DC

Mr. Daniel Carestio (52)

President, Chief Executive Officer, Director · since 2015

10.67 M USD

Management

MT

Mr. Michael Tokich (56)

Chief Financial Officer, Senior Vice President

3.31 M USD
JZ

Mr. John Zangerle (58)

Senior Vice President, General Counsel, Company Secretary

2.94 M USD
CM

Mr. Cary Majors (50)

Senior Vice President and President - Healthcare

2.22 M USD
MF

Ms. Mary Fraser (54)

Chief Human Resources Officer, Senior Vice President

1.89 M USD
KB

Ms. Karen Burton (58)

Chief Financial Officer, Senior Vice President

–
KK

Mr. Kenneth Kohler (62)

Senior Vice President, General Manager - AST

–

Board of Directors

MS

Dr. Mohsen Sohi (66)

Independent Chairman of the Board

503,868.00 USD
RB

Mr. Richard Breeden (75)

Independent Director

353,903.00 USD
CF

Ms. Cynthia Feldmann (72)

Independent Director

349,852.00 USD
PM

Mr. Paul Martin (67)

Independent Director

342,352.00 USD
CH

Mr. Christopher Holland (58)

Independent Director

342,303.00 USD
NS

Dr. Nirav Shah (53)

Independent Director

336,352.00 USD

STERIS plc Supply Chain

STERIS plc Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
5 companies
#Nameβ 1YTrend
1
Stille AB
Supplier·Health Care Equipment & Supplies·SE
-0.61
0.49
0.45
0.04
0.20
0.75
—
2
Thermon Group Holdings, Inc.
Supplier·Electrical Equipment·US
0.75
0.81
-0.31
-0.27
-0.11
0.45
-0.16
3
Austar Lifesciences Limited
Supplier·Life Sciences Tools & Services·CN
-0.34
0.66
0.63
-0.11
-0.35
0.41
—
#Nameβ 1YTrend
1
Prophecy International Holdings Limited
Supplier·Software·AU
0.28
0.68
-0.17
-0.06
0.76
—
—
2
Covetrus Inc
Customer·Health Care Providers & Services·US
0.74
0.85
0
0.02
-0.77
-0.41
—

Frequently asked questions about STERIS plc

The business model of Steris plc revolves around providing innovative and comprehensive solutions in the healthcare industry. As a global leader, Steris plc focuses on offering products and services that enhance infection prevention, sterilization, and surgical efficiency. With a wide range of offerings including equipment, consumables, and software solutions, Steris plc aims to improve patient outcomes and increase operational productivity for hospitals and healthcare facilities worldwide. Their dedication to advanced technologies and patient safety has earned them a strong reputation in the industry.

Steris plc is primarily active in the healthcare industry. As a global leader, Steris provides innovative solutions and products focused on infection prevention, cleaning, and sterilization for healthcare facilities. With a wide range of offerings, Steris caters to hospitals, ambulatory surgical centers, pharmaceutical companies, and other healthcare institutions. By leveraging its expertise and advanced technologies, Steris aims to enhance patient safety, improve operational efficiency, and support healthcare professionals in delivering high-quality care.

The main competitors of Steris plc in the market include companies such as Johnson & Johnson, 3M Company, and Cantel Medical Corp. These companies operate in the same sector as Steris plc and provide similar products and services. However, Steris plc stands out due to its strong position in the market, diverse product portfolio, and robust customer base. With its innovative solutions and consistent focus on customer satisfaction, Steris plc continues to stay ahead of its competitors in the industry.

Steris plc is a leading global provider of infection prevention and surgical products, services, and technologies. The company was founded in 1985 as Innovative Medical Technologies and later changed its name to Steris Corporation. In 2015, Steris Corporation merged with Synergy Health plc to become Steris plc. With a rich history spanning over three decades, Steris plc has been dedicated to advancing healthcare and related industries. The company offers a wide range of solutions, including sterilization systems, surgical tables, detergents, and disinfectants. Steris plc has established itself as a trusted name in the medical and life sciences sectors, constantly striving to enhance patient safety and improve healthcare outcomes.

Steris plc, a leading company in the medical technology field, has achieved several significant milestones over the years. One noteworthy accomplishment is the acquisition of Synergy Health, which allowed Steris plc to expand its product portfolio and strengthen its global presence. Additionally, the company made strides in research and development, launching innovative solutions such as the Sterrad NX and System 1E, which revolutionized sterilization practices in healthcare settings. Steris plc also gained recognition for its commitment to quality, receiving ISO 9001 certification for its manufacturing facilities. These milestones highlight Steris plc's dedication to delivering advanced and reliable medical technology solutions to its customers worldwide.

Steris plc is primarily present in several countries and regions around the world. As a global company, Steris plc has a significant presence in the United States, where it is headquartered. It also operates in various regions including Europe, Asia, and Latin America. The company's international presence allows it to serve a diverse range of customers and expand its market reach. With a strong focus on providing innovative infection prevention and sterilization solutions, Steris plc continues to establish itself as a leader in the healthcare and life sciences industries worldwide.

Steris plc is a global leader in infection prevention, sterilization, and surgical products and services. The values and corporate philosophy that define Steris plc revolve around their commitment to enhancing healthcare safety and improving the quality of patient care. The company focuses on delivering innovative solutions that enable healthcare professionals to create a safer environment for their patients. Steris plc consistently strives for excellence, constantly innovating and improving to meet the evolving needs of healthcare providers worldwide. With a strong emphasis on integrity, collaboration, and customer-centricity, Steris plc is dedicated to driving positive changes in healthcare practices and improving outcomes for patients.

Analysts currently set an average price target of 287.85 USD for the STERIS plc stock (median: 296.82 USD), implying +21.2 % versus the latest price. The consensus is based on 14 analyst ratings.

STERIS plc Analyst Price Targets 2026

14 analysts currently rate the STERIS plc stock: 9 recommend buying, 5 holding and 0 selling.

STERIS plc Analyst Price Targets 2026

Converted at the current exchange rate, the STERIS plc share trades at 205.53 EUR (237.47 USD).

The STERIS plc share (STE) is listed on 3 stock exchanges, including: NYSE (STE), Frankfurt (2TG.F), London (0XI8.L).

Steris plc is a globally leading company in the field of sterilization and disinfection of medical instruments and facilities. Its business model is based on three main divisions: Healthcare Products, Healthcare Specialty Services, and Life Sciences. Steris offers a wide range of products and services to ensure effective sterilization and disinfection in the medical field. The company is committed to continuous improvement and innovation to meet customer needs. It also prioritizes sustainability and works closely with customers to develop tailored solutions.

The revenue of STERIS plc is 5.94 B USD. This figure is based on current financial data and reflects the company's business performance.

The profit of STERIS plc is 785.10 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of STERIS plc is currently 29.76. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the STERIS plc stock.

The price-to-sales ratio (P/S) of STERIS plc is currently 3.94. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the STERIS plc stock.

The Eulerpool Quality Score for STERIS plc is 7/10.

The ISIN of STERIS plc is IE00BFY8C754. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of STERIS plc is A2PGLV. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of STERIS plc is STE. The ticker symbol is used to trade STERIS plc shares on the stock exchange.

Over the past 12 months, STERIS plc paid a dividend of 2.46 USD . This corresponds to a dividend yield of about 1.04 %. For the coming 12 months, STERIS plc is expected to pay a dividend of 2.52 USD.

The current dividend yield of STERIS plc is 1.04 %.

STERIS plc pays a dividend, distributed in the months of , , , .

STERIS plc paid dividends every year for the past 21 years.

For the upcoming 12 months, dividends amounting to 2.52 USD are expected. This corresponds to a dividend yield of 1.09 %.

STERIS plc is assigned to the 'Health' sector.

In the year 2025, STERIS plc distributed 2.23 USD as dividends.

The dividends of STERIS plc are distributed in USD.

All fundamentals and in-depth analysis of STERIS plc

Our stock analysis for STERIS plc stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of STERIS plc. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

STERIS plc Stock
STERIS plc Revenue→
STERIS plc Stock
STERIS plc Net Income→
STERIS plc Stock
STERIS plc P/E→
STERIS plc Stock
STERIS plc P/S→
STERIS plc Stock
STERIS plc EBIT→
STERIS plc Stock
STERIS plc Dividend→
STERIS plc Stock
STERIS plc Directors Dealings→
STERIS plc Stock
STERIS plc Stocks→
STERIS plc Stock
STERIS plc Market capitalization→
STERIS plc Stock
STERIS plc Debt→
STERIS plc Stock
STERIS plc Liabilities→
STERIS plc Stock
STERIS plc Equity→
STERIS plc Stock
STERIS plc AAQS→
STERIS plc Stock
STERIS plc Employees→
STERIS plc Stock
STERIS plc ROE→
STERIS plc Stock
STERIS plc ROA→
STERIS plc Stock
STERIS plc ROCE→
STERIS plc Stock
STERIS plc News→
STERIS plc Stock
STERIS plc Analyst Price Targets→

Health Stocks

Stevanato Group SpAStereotaxisStilleStenocare A/SStimCell EnegeticsStemRIMStoke TherapeuticsStemCell InstituteStrata Skin SciencesStem HoldingsStratec SeStem Cells SpinAll Stocks A–Z →